Overview

Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
A study of patients with type 2 diabetes and inadequate glycemic control on two or more oral antihyperglycemic agents comparing adding insulin lispro mid mixture to the oral antihyperglycemic agents to adding insulin glargine to the oral antihyperglycemic agents.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin Glargine
Insulin Lispro
Insulin, Globin Zinc